Background: Gastricb alloon therapy(GBT)i satemporay, nonsurgicaltreatmentforobesity.Thisr etrospectivestudy evaluatessafety and efficacyof GBT in obesepatients. 
Introduction
Among the differentt reatmentoptionsforobesity,the implantation of ani ntragastricb alloon represents atemporary,nonsurgical intervention. Gastricb alloon therapy(GBT)i sconsidered tobea restrictivep rocedurethatiscompletelyr eversible and repeatable atanyt ime [1, 2] .The intragastricb alloon consists of asoft,flexible silicone elastomerw hichi simplanted intothe patient'ss tomachand filled withsaline solution toavolume of approximately 700 ml ( fig. 1 ). Balloon placementand removalisperformed under endoscopicc ontrol. The intragastricb alloon isdesigned tom echanicallyprovide asensation of satiety,resulting in decreased food ingestion and facilitated learning of dietary and newbehavioralroutines [3] .Itr emainsin the gastricc avity foraperiod of usually6months. Therearem ainlyt wog roupsof patients forw hichGBT isindicated:patients who do notfulfill the criteriaforbariatricsurgery and super-obesep atients (BMI > 50kg/m 2 )who haveahigh surgicalriskd uetotheirexcessiveweight.Inthesep atients,weightr eduction through GBT mayhelp reduceseverecomorbiditiesand surgicalrisksbeforesubsequentbariatricorothers urgery.Ithas been shownthatamodest preoperativeweightloss of 10-20%re-ducesthe complicationsof surgery [4] . Thisr etrospectivestudyevaluatest he safety and efficacyof GBT withemphasison preoperativeweightreduction.
Patients and Methods

Patients
The BioEnterics Ò IntragastricB alloon (BIB Ò )( BioEntericsCorporation; Carpinteria, CA, USA)wasu sed forall patients.Patients received GBT eitherasapreoperativeproceduretoreduceseverecomorbiditiesand surgicalrisksorasanalternativeupon refusalo fconventionalsurgicaltreatment duetofearof complications.All patients hadbeen obeseforatleast 5years and hadfailed toachieveweightloss on anadequateweightcontrol program formorethan3years.All patients werescreenedformajorendocrine disorders.
Exclusion criteriaforGBT were:(1) age <16and >70,(2)n eoplasia, (3) pregnancy,(4) alcohol ordrugabuse. Contraindicationsrelated morespecificallytothe balloon consisted of (5) previous bariatricorgastrointestinalsurgery and (6)g astrointestinall esionsr evealed bygastroscopy:neoplasticlesions,large hiatalh ernia(> 5cm),grade III esophagitis,duodenalo rgastric ulcer,lesionsconsidered atr iskf orbleeding. Written informed consentw as obtained from all treated patients.
Balloon Insertion and Removal BIB insertion intothe stomachwasperformed endoscopicallyu nderconscious sedation. Esophagus,stomachand duodenumwerethoroughlyinspected bygastroscopytorule out anystructuralabnormalities.Atimplantation,the balloon wasplaced in the stomachand inflated underdirectendoscopicvision withsaline /0.1% methyleneblue( 450-750ml). Onceable to tolerateoralfluids,patients weredischarged from the hospitalwitharegular proton pump inhibitorand,if required,spasmolyticand anti-emeticmedication. The patients wereadvised too bserveafullyliquid dietfort he first week, progress toh alf-solid food during the second week,a nd then continuewith regularmealsunderspecificdietary instructionsbyadietitian. Follow-upregarding toleranceand efficacyevaluationaswell aspatients'eating protocol and quality of life questionnaireassessmentw erep erformed at1,3and 6monthsafterballoon insertion. Patients wereevaluated byamultidisciplinary teamconsisting of abariatricsurgeon,aninternist,adietician,and aphysiotherapist.Balloon removalwasr outinelyplanned after6months.Under conscious sedation,diagnosticendoscopyw asperformed and the BIBwas removed. 
Results
PatientDemographics
Discussion
The aim of thisretrospectivestudywastoinvestigatethe safety,efficacy,a nd preoperativeweightr eduction of intragastricb alloon therapy.The results indicatethatBIB insertion isasafe,tolerable, and potentiallyeffectiveprocedureforthe initialtreatmentof morbid obesity.
Efficacyand Safety of GBT Therewerem inimalcomplicationsassociated withballoon placementand removal(0.9% and 2.8%,respectively). Nomortality occurred in our cohort.Furthermore,no majorcomplication suchas balloon deflation,intestinalo bstruction,orgastricperforation occurred in our patients.Inagreementwithour results,ameta-analysisof 15 studiesanalyzing morethan3,600 patients confirmed the safety of GBT [5] . Compared too therBIB studies,weachieved amoderate,though above-average weightloss of 21.2 -14.0kg withameanBMI loss and EBL of 7.2 -4.9 kg/m 2 and 30.1 -26.4%,respectively [6] .BIB isatemporary anti-obesity treatmentw hichi nducesonlyashorttermweightloss [7] .Severalstudieshaveshownthatw eightloss reversesafterballoon removal [8] [9] [10] .Analysisof the long-term weightloss hass hownthatt he patients regain 40%o ftheirpretreatmentexcessiveweight1yearafterBIB explantation [6] .GBT doesnots eem tobeanalternativetosurgery forindividualsw ith morbid obesity asitisdesigned toremain in the stomachf oronly 6months.Compared tosurgicaltreatment,G BT canbeattractive topatients asitisless invasivethansurgery.
PreoperativeWeightReduction withGBT
Until today,the onlyeffectivel ong-termtreatmentforextreme obesity isbariatricsurgery.Although the introduction of laparoscopyt othe field of bariatricsurgery hasimproved results and reduced complications,the operativem anagementof super-obese patients presents amajort echnicalchallenge forbothsurgeons and anesthetists.Extreme obesity causesdifficultiesin intubation and mechanicalventilation during anesthesia [ 11, 12] .Surgical technicald ifficultiesincreasethe risko fp erioperativecomplicationsand arerelated to:(1) thickabdominalwallshindering control of laparoscopicinstruments and complication of the necessary surgicalm aneuvers; (2)e xcessiveo mentaland intra-abdominalf at deposition causing anundersized operation field withalimited field of vision;(3)h epatomegalyr esulting in difficultliverr etraction and constrained exposure [13] [14] [15] . [18, 19] . Inconclusion,G BT represents ausefulbut temporary wayof achieving avitalBMI improvementin extremelyobesep atients, particularlyasafirst step beforeadefinitiveanti-obesity operation. When applied in specialized institutionsw ithl ong-standing experiencei nthe treatmentof obesity,the BIB canbesafely placed even in theseh igh-risko besep atients.The implementation of GBT in amultidisciplinary setting isof imperativevalue.
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